Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.2.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Three Months
Ended September 30,
    For the Nine Months
Ended September 30,
 
    2022     2021     2022     2021  
Research and development   $ 17,639     $ 23,362     $ 64,048     $ 200,092  
General and administrative     372,423       658,473       1,217,393       1,759,745  
Total   $ 390,062     $ 681,835     $ 1,281,441     $ 1,959,837  

 

Schedule of stock option activity
                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2021     366,411       204,230     $ 51.30     $ 47.40     $ 47.40       6.27     $        -  
Granted     19,367       278       10.42       10.42       4.53       6.27       -  
Exercised     -       -       -       -       -       -       -  
Cancelled     (53,227 )     -       -       -       -       -       -  
Balance  – September 30, 2022     332,551       197,585     $ 49.08     $ 43.12     $ 43.12       6.27     $ -  

 

Schedule of stock options outstanding and exercisable
Grant Price     Weighted
Average
    Total     Number     Weighted
Average
Remaining
Contractual
 
From     To     Exercise Price     Outstanding     Exercisable     Term  
$ 6.00     $ 60.60     $ 34.41       270,963       138,680     7.46 years  
$ 63.00     $ 138.00     $ 82.13       46,821       44,138     5.46 years  
$ 159.00     $ 265.80     $ 193.28       14,767       14,767     5.60 years  
                  Totals       332,551       197,585                     

 

Schedule of warrants activity
                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2021     1,187,803       1,187,664     $ 31.35     $ 31.35     $ 15.90       4.38     $       -  
Granted     -       -       -       -       -       -       -  
Exercised     -       -       -       -       -       -       -  
Cancelled     (9,634 )     -       -       -       -       -       -  
Balance  – September 30, 2022     1,178,169       1,178,169     $ 30.67     $ 30.67     $ 17.83       3.66     $ -